...
首页> 外文期刊>Therapeutic Drug Monitoring >Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.
【24h】

Early phase limited sampling strategy characterizing tacrolimus and mycophenolic acid pharmacokinetics adapted to the maintenance phase of renal transplant patients.

机译:早期阶段有限的采样策略表征了他克莫司和麦考酚酸的药代动力学,适用于肾移植患者的维持阶段。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to examine whether a limited sampling strategy (LSS) to allow the simultaneous estimation of the area under the concentration-time curves (AUCs) of tacrolimus and mycophenolic acid (MPA) calculated in the early stage after renal transplantation could be applied to maintenance phase pharmacokinetics. Seventy Japanese patients were enrolled. One year after transplantation, samples were collected just before and 1, 2, 3, 4, 6, 9, and 12 hours after tacrolimus and mycophenolate mofetil administration at 9:00 am and at 9:00 pm. The prediction formulas on day 28 (tacrolimus AUC 0-12 = 7.04 x C 0h + 1.71 x C 2h + 3.23 x C 4h + 15.19 and 2.25 x C 2h + 1.92 x C 4h + 7.27 x C 9h + 6.61, and MPA AUC 0-12 = 0.26 x C 0h + 2.06 x C 2h + 3.82 x C 4h + 20.38 and 1.77 x C 2h + 2.34 x C 4h + 4.76 x C 9h + 15.94) were applied to pharmacokinetic data obtained at 1 year. Three error indices [percent mean prediction error (ME), % mean absolute error, and percent root mean squared prediction error (RMSE)] were used to evaluate the predictive bias, accuracy, and precision. The predicted AUC 0-12 of tacrolimus and MPA at 3 time points, C 2h-C 4h-C 9h, showed higher correlation with the measured AUC 0-12 of tacrolimus and MPA (r2 = 0.817 and 0.789, respectively) in comparison with those at C 0h-C 2h-C 4h. The values for the prediction formulas for tacrolimus AUC at 1 year using the C 2h-C 4h-C 9h combination yielded less than 5% for %ME and 15% for %RMSE. The %ME and %RMSE values of the prediction formulas for tacrolimus AUC using the C 0h-C 2h-C 4h combination were 6.3% and 15.9%, respectively. The %ME and %RMSE values of the prediction formulas for MPA AUC at 1 year using the C 0h-C 2h-C 4h combination were 5.9% and 25.8%, respectively, and those for the C 2h-C 4h-C 9h combination were 4.9% and 21.2%, respectively. AUC 6-12/AUC 0-12 of MPA 1 year after transplantation was significantly lower than 28 days after transplantation. An LSS using C 2h-C 4h-C 9h seems to be applicable for predicting the AUC of tacrolimus and MPA at either posttransplantation stage. The enterohepatic circulation of MPA was significantly reduced 1 year after transplantation. Therefore, 1 year after transplantation, the estimation of the AUC 0-12 of MPA for the C 0h-C 2h-C 4h equations was imprecise. It is important that the LSS includes C 9h because it contains information on the secondary plasma peak of MPA.
机译:这项研究的目的是检查有限的采样策略(LSS)是否可以同时估计肾移植术后早期他克莫司和霉酚酸(MPA)的浓度-时间曲线(AUC)下的面积用于维持阶段的药代动力学。招募了70名日本患者。移植后一年,在他克莫司和霉酚酸酯的施用开始前,9:00、9:00和pm之前,1、2、3、4、6、9和12小时之前收集样品。第28天的预测公式(他克莫司AUC 0-12 = 7.04 x C 0h + 1.71 x C 2h + 3.23 x C 4h + 15.19和2.25 x C 2h + 1.92 x C 4h + 7.27 x C 9h + 6.61,以及MPA AUC将0-12 = 0.26 x C 0h + 2.06 x C 2h + 3.82 x C 4h + 20.38和1.77 x C 2h + 2.34 x C 4h + 4.76 x C 9h + 15.94)应用于1年时获得的药代动力学数据。使用三个误差指数[平均预测误差百分比(ME),平均绝对误差百分比和均方根误差百分比(RMSE)]来评估预测偏差,准确性和精度。他克莫司和MPA在3个时间点C 2h-C 4h-C 9h的预测AUC 0-12与他克莫司和MPA的测得AUC 0-12的相关性更高(分别为r2 = 0.817和0.789)。 C 0h-C 2h-C 4h的那些。使用C 2h-C 4h-C 9h组合时,他克莫司AUC在1年时的预测公式的值得出%ME小于5%,%RMSE小于15%。使用C 0h-C 2h-C 4h组合的他克莫司AUC预测公式的%ME和%RMSE值分别为6.3%和15.9%。使用C 0h-C 2h-C 4h组合时,MPA AUC的1年预测公式的%ME和%RMSE值分别为C 2h-C 4h-C 9h组合的5.9%和25.8%。分别为4.9%和21.2%。移植后1年MPA的AUC 6-12 / AUC 0-12显着低于移植后28天。使用C 2h-C 4h-C 9h的LSS似乎可用于预测他克莫司和MPA在任一移植后阶段的AUC。移植后1年,MPA的肝肠循环明显减少。因此,在移植后1年,对于C 0h-C 2h-C 4h方程,MPA的AUC 0-12的估算是不精确的。 LSS包含C 9h很重要,因为它包含有关MPA的次级血浆峰的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号